Mitsubishi UFJ Asset Management Co. Ltd. Has $2.12 Million Stock Holdings in Liquidia Co. (NASDAQ:LQDA)

Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 13.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,172 shares of the company's stock after purchasing an additional 20,171 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.20% of Liquidia worth $2,116,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of LQDA. Intech Investment Management LLC acquired a new position in shares of Liquidia during the third quarter worth approximately $195,000. Charles Schwab Investment Management Inc. grew its holdings in Liquidia by 144.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 390,257 shares of the company's stock worth $3,903,000 after acquiring an additional 230,820 shares during the period. BNP Paribas Financial Markets raised its position in shares of Liquidia by 735.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 140,190 shares of the company's stock valued at $1,402,000 after acquiring an additional 123,402 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Liquidia by 43.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,708 shares of the company's stock valued at $187,000 after purchasing an additional 5,669 shares during the period. Finally, Walleye Trading LLC boosted its position in shares of Liquidia by 54.7% in the 3rd quarter. Walleye Trading LLC now owns 13,201 shares of the company's stock worth $132,000 after purchasing an additional 4,670 shares during the last quarter. Institutional investors own 64.54% of the company's stock.

Remove Ads

Liquidia Stock Performance

Liquidia stock traded down $1.23 during mid-day trading on Friday, reaching $12.90. The company's stock had a trading volume of 1,900,899 shares, compared to its average volume of 943,491. Liquidia Co. has a 12 month low of $8.26 and a 12 month high of $16.81. The business's 50 day simple moving average is $15.14 and its 200 day simple moving average is $12.59. The company has a market capitalization of $1.10 billion, a price-to-earnings ratio of -7.91 and a beta of 0.23.

Liquidia (NASDAQ:LQDA - Get Free Report) last released its earnings results on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The company had revenue of $2.92 million for the quarter, compared to the consensus estimate of $4.60 million. Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%. As a group, sell-side analysts expect that Liquidia Co. will post -1.51 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Wells Fargo & Company started coverage on Liquidia in a research report on Friday, December 20th. They set an "overweight" rating and a $20.00 target price for the company. Needham & Company LLC boosted their price objective on Liquidia from $19.00 to $25.00 and gave the company a "buy" rating in a research report on Thursday, March 20th. HC Wainwright restated a "buy" rating and set a $29.00 target price on shares of Liquidia in a report on Thursday, March 20th. Finally, Scotiabank reissued an "outperform" rating on shares of Liquidia in a research report on Thursday, March 20th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $26.63.

Insider Buying and Selling

In related news, General Counsel Russell Schundler sold 16,393 shares of the business's stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total transaction of $193,109.54. Following the transaction, the general counsel now directly owns 573,478 shares of the company's stock, valued at approximately $6,755,570.84. The trade was a 2.78 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Rajeev Saggar sold 6,249 shares of Liquidia stock in a transaction on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total transaction of $73,613.22. Following the transaction, the insider now directly owns 270,388 shares of the company's stock, valued at approximately $3,185,170.64. This trade represents a 2.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 71,245 shares of company stock worth $843,326. Insiders own 30.10% of the company's stock.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).